Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionSphera Funds Management Ltd.
Latest Disclosed Ownership603,377 shares
Latest Disclosed Value $ 8,724,831
Sphera Funds Management Ltd. ownership in FOLD / Amicus Therapeutics, Inc.

On May 15, 2026 - Sphera Funds Management Ltd. filed a 13F-HR form disclosing ownership of 603,377 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $8,724,831 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 658,377 shares of Amicus Therapeutics, Inc.. This represents a change in shares of -8.35% during the quarter. The current value of the position is $8,742,933 USD.

Sphera Funds Management Ltd. has a history of taking positions in derivatives of the underlying security (FOLD) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

FOLD / Amicus Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 603,377 -55,000 -8.35 8,725 -6.94 1.3856
2026-02-17 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 658,377 -332,765 -33.57 9,375 20.04 1.8124
2025-11-14 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 991,142 424 0.04 7,810 37.60 1.6475
2025-08-14 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 990,718 990,718 5,677 1.3321
2022-11-14 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 0 -753,037 -100.00 0 -100.00
2022-08-15 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 753,037 753,037 8,088 0.8652
2022-02-14 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -491,159 -100.00 0 -100.00
2021-11-15 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 491,159 491,159 4,691 0.3941
2021-05-17 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -265,753 -100.00 0 -100.00
2021-02-16 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 265,753 -977,797 -78.63 6,136 -65.05 0.5446
2020-11-12 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,243,550 -385,000 -23.64 17,559 -28.50 1.7254
2020-08-13 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,628,550 -389,074 -19.28 24,559 31.73 2.3096
2020-05-14 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 2,017,624 -782,696 -27.95 18,643 -31.65 2.3317
2020-02-13 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 2,800,320 -130,000 -4.44 27,275 16.06 2.2477
2019-11-14 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 2,930,320 420,000 16.73 23,501 -24.99 3.6305
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 2,510,320 22,242 0.89 31,329 -7.41 4.2858
2019-05-15 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 2,488,078 40,084 1.64 33,838 44.29 3.1089
2019-02-14 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 2,447,994 660,000 36.91 23,452 8.49 2.6434
2018-11-14 2018-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,787,994 598,938 50.37 21,617 16.39 2.4817
2018-08-13 2018-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,189,056 -656,648 -35.58 18,573 -33.09 2.5605
2018-05-10 2018-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,845,704 745,704 67.79 27,759 75.37 4.2145
2018-02-12 2017-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,100,000 680,000 161.90 15,829 149.91 1.8574
2017-11-27 2017-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 420,000 20,000 5.00 6,334 57.25 0.9037
2017-11-09 2017-09-30 13F AMICUS THERAPEUTICS COM 03152W109 420,000 20,000 6,334
2017-08-09 2017-06-30 13F AMICUS THERAPEUTICS COM 03152W109 400,000 -100,000 -20.00 4,028 12.99 0.6844
2017-05-11 2017-03-31 13F AMICUS THERAPEUTICS COM 03152W109 500,000 -230,000 -31.51 3,565 -1.74 0.6969
2017-02-13 2016-12-31 13F AMICUS THERAPEUTICS COM 03152W109 730,000 -175,000 -19.34 3,628 -45.83 0.9184
2016-11-14 2016-09-30 13F AMICUS THERAPEUTICS COM 03152W109 905,000 -100,000 -9.95 6,697 22.05 1.0904
2016-08-10 2016-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,005,000 705,000 235.00 5,487 116.45 1.4246
2016-05-16 2016-03-31 13F AMICUS THERAPEUTICS COM 03152W109 300,000 300,000 0.00 2,535 0.5495
2016-02-11 2015-12-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -310,000 -100.00 0 -100.00
2015-11-16 2015-09-30 13F AMICUS THERAPEUTICS COM 03152W109 310,000 -140,000 -31.11 4,337 -31.89 0.5533
2015-08-06 2015-06-30 13F AMICUS THERAPEUTICS COM 03152W109 450,000 0 0.00 6,368 30.07 0.6238
2015-05-11 2015-03-31 13F AMICUS THERAPEUTICS COM 03152W109 450,000 -100,000 -18.18 4,896 6.99 0.5097
2015-02-12 2014-12-31 13F Amicus Therapeutics COM 03152W109 550,000 550,000 4,576 0.7796
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2016-08-10 2016-06-30 13F AMICUS THERAPEUTICS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-16 2016-03-31 13F AMICUS THERAPEUTICS PUT Put 300,000 2,535 n/a n/a n/a
2016-02-11 2015-12-31 13F AMICUS THERAPEUTICS PUT Put 0 0 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.